Shares of Sanofi slumped on Monday as the French drugmaker said a U.S. regulatory review of its multiple-sclerosis drug won’t be completed by the end of the year and that a trial for a different form of MS didn’t succeed.
Visualizing The Complete History Of European Colonization
Visualizing The Complete History Of European Colonization Europe’s colonial empires have shaped the world’s political and economic systems for…
